Cardiovascular system medicine use in Canada exhibits a steady growth trajectory. The data reveals that from 2023 to 2024, there was an increase from a baseline of 514.7 units per thousand persons per day, reaching 519.7 by 2028. The year-on-year variation demonstrates marginal increases: from 2024 to 2025 (+0.33%), from 2025 to 2026 (+0.27%), from 2026 to 2027 (+0.21%), and from 2027 to 2028 (+0.15%). The Compound Annual Growth Rate (CAGR) over the five-year period stands at approximately +0.24% annually.
Several future trends to watch for include potential advancements in cardiovascular treatments, changes in healthcare policy, an aging population, and the impact of lifestyle diseases on medicine demand. Monitoring these factors will be crucial to understanding and anticipating shifts in cardiovascular medicine use.
